Nurix Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRIX and other ETFs, options, and stocks.

About NRIX

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. 

CEO
Arthur T. Sands
CEOArthur T. Sands
Employees
286
Employees286
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2009
Founded2009
Employees
286
Employees286

NRIX Key Statistics

Market cap
989.04M
Market cap989.04M
Price-Earnings ratio
-4.50
Price-Earnings ratio-4.50
Dividend yield
—
Dividend yield—
Average volume
1.08M
Average volume1.08M
High today
$13.67
High today$13.67
Low today
$12.75
Low today$12.75
Open price
$13.66
Open price$13.66
Volume
2.23M
Volume2.23M
52 Week high
$29.56
52 Week high$29.56
52 Week low
$11.90
52 Week low$11.90

Analyst ratings

89%

of 18 ratings
Buy
88.9%
Hold
11.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.